US 7501501
MHC-Class II restricted melanoma antigens and their use in therapeutic methods
granted A61KA61K39/00
Quick answer
US patent 7501501 (MHC-Class II restricted melanoma antigens and their use in therapeutic methods) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K39/00